Monitoring the response to neoadjuvant chemotherapy in patients with breast cancer using ultrasound scattering coefficient: A preliminary report

Monitoring the response to neoadjuvant chemotherapy in patients with breast cancer using ultrasound scattering coefficient: A preliminary report

Objective: Neoadjuvant chemotherapy was initially used in locally advanced breast cancer, and currently it is recommended for patients with Stage 3 and with early-stage disease with human epidermal growth factor receptors positive or triple-negative breast cancer. Ultrasound imaging in combination w...

Full description

Bibliographic Details
Main Authors:	Katarzyna Dobruch-Sobczak, Hanna Piotrzkowska-Wróblewska, Ziemowit Klimoda, Wojciech Secomski, Piotr Karwat, Ewa Markiewicz-Grodzicka, Agnieszka Kolasińska-Ćwikła, Katarzyna Roszkowska-Purska, Jerzy Litniewski
Format:	Article
Language:	English
Published:	Sciendo 2019-06-01
Series:	Journal of Ultrasonography
Subjects:	integrated backscatter coefficient (ibscs) neoadjuvant chemotherapy (nac) breast cancer ultrasound
Online Access:	http://www.jultrason.pl/index.php/issues/volume-19-no-77/monitoring-the-response-to-neoadjuvant-chemotherapy-in-patients-with-breast-cancer-using-ultrasound-scattering-coefficient-a-preliminary-report?aid=712

Similar Items

Quantitative ultrasonography as a tool for the evaluation of breast tumor response to neoadjuvant chemotherapy
by: Piotrzkowska-Wróblewska Hanna, et al.
Published: (2022-04-01)

Explaining a deep learning based breast ultrasound image classifier with saliency maps
by: Byra Michał, et al.
Published: (2022-04-01)

Tuning Intermediate Band Solar Cell Efficiency: The Interplay of Electric Fields, Composition, Impurities, and Confinement
by: Hassan Abboudi, et al.
Published: (2024-11-01)

Cribriform carcinoma mimicking breast abscess – case report. Diagnostic and therapeutic management
by: Katarzyna Dobruch‑Sobczak, et al.
Published: (2013-06-01)

Advances in Imaging in Evaluating the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
by: Xianshu Kong, et al.
Published: (2022-05-01)

Efficiency of InN/InGaN/GaN Intermediate-Band Solar Cell under the Effects of Hydrostatic Pressure, In-Compositions, Built-in-Electric Field, Confinement, and Thickness
by: Hassan Abboudi, et al.
Published: (2024-01-01)

Should an intercalated degree be compulsory for undergraduate medical students?
by: Aaron B. Philip, et al.
Published: (2015-10-01)

Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study
by: Joon Young Choi, et al.
Published: (2023-10-01)

Changes in the immune landscape of TNBC after neoadjuvant chemotherapy: correlation with relapse
by: Mohammed Ridha Moamin, et al.
Published: (2023-11-01)

Efficacy and Safety of Neoadjuvant Chemotherapy Combined with Adjuvant Chemotherapy for Locally Advanced Colon Cancer: A Propensity Score-Matching Analysis
by: Wei Zeng, et al.
Published: (2022-10-01)

Immunohistochemical subtypes of the breast cancer in the ultrasound and clinical aspect – literature review
by: Dobruch-Sobczak Katarzyna, et al.
Published: (2022-04-01)

Sarcoidosis of the breasts – when should it be considered? A case report
by: Jaguś Dominika, et al.
Published: (2022-04-01)

Perioperative versus adjuvant chemotherapy for resectable gastric cancer: a meta-analysis of randomized controlled trials
by: Haiya Ou, et al.
Published: (2025-03-01)

The potential role of combined shear wave elastography and superb microvascular imaging for early prediction the pathological response to neoadjuvant chemotherapy in breast cancer
by: Jiaojiao Qi, et al.
Published: (2023-09-01)

Neoadjuvant chemotherapy may be the best neoadjuvant therapy modality for non-metastatic pancreatic cancer: a population based study
by: Jie Yang, et al.
Published: (2024-04-01)

Multiparametric ultrasound assessment of axillary lymph nodes in patients with breast cancer
by: Katarzyna Dobruch-Sobczak, et al.
Published: (2024-10-01)

Comparison of BSGI and MRI as Approaches to Evaluating Residual Tumor Status after Neoadjuvant Chemotherapy in Chinese Women with Breast Cancer
by: Hongbiao Liu, et al.
Published: (2021-10-01)

Advantages and advances in neoadjuvant therapy of pancreatic cancer
by: HU Binwei, SHEN Baiyong
Published: (2024-01-01)

A randomized phase 3 trial of total neoadjuvant therapy (induction chemotherapy, neoadjuvant chemoradiation, neoadjuvant chemotherapy, and surgery) vs. standard long-term chemoradiation therapy (neoadjuvant chemoradiation, surgery, and adjuvant chemotherapy) in locally advanced rectal cancer
by: Freshte Foroughi, et al.
Published: (2024-12-01)

Neoadjuvant and Adjuvant Chemotherapy in Osteosarcoma (The Experience of HORC in the Shariati Hospital)
by: Alimoghadam K, et al.
Published: (2004-07-01)

Neoadjuvant treatment for breast cancer
by: V. F. Semiglazov, et al.
Published: (2014-07-01)

Retrospective Evaluation of the Efficacy of Total Neoadjuvant Therapy and Chemoradiotherapy Neoadjuvant Treatment in Relation to Surgery in Patients with Rectal Cancer
by: Lucian Dragoș Bratu, et al.
Published: (2024-04-01)

Neoadjuvant strategies in resectable carcinoma esophagus: a meta-analysis of randomized trials
by: Tarun Kumar, et al.
Published: (2020-03-01)

Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study
by: Wenwu He, et al.
Published: (2022-06-01)

Comparison of Standard Neoadjuvant Therapy and Total Neoadjuvant Therapy in Terms of Effectiveness in Patients Diagnosed with Locally Advanced Rectal Cancer
by: Ayberk Bayramgil, et al.
Published: (2025-02-01)

Neoadjuvant and Adjuvant Chemotherapy in Osteosarcoma (The Experience of HORC in the Shariati Hospital)
by: K Alimoghadam, et al.
Published: (2004-03-01)

Does neoadjuvant rectal score predict treatment outcomes better than the all grading systems used in neoadjuvantly treated rectal cancer?
by: Fatma Sert, et al.
Published: (2023-10-01)

Neoadjuvant chemotherapy for colon cancer
by: M. Yu. Fedyanin, et al.
Published: (2022-06-01)

Neoadjuvant Immunotherapy for Hepatocellular Carcinoma
by: Marron TU, et al.
Published: (2022-06-01)

Neoadjuvant treatment for pancreatic cancer: Controversies and advances
by: Douglas Dias e Silva, et al.
Published: (2024-01-01)

Short- and long-term outcomes of neoadjuvant chemotherapy compared with neoadjuvant chemoradiotherapy for locally advanced rectal cancer: an updated meta-analysis
by: Yue Guo, et al.
Published: (2025-02-01)

2-CONSERVATIVE TREATMENT OF RECTAL ADENOCARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY, IS IT ACCEPTABLE?
by: Majeed H Alwan
Published: (2009-06-01)

Molecular and Clinicopathological Biomarkers in the Neoadjuvant Treatment of Patients with Advanced Resectable Melanoma
by: Piotr J. Błoński, et al.
Published: (2024-03-01)

Evaluation of neoadjuvant immunotherapy and traditional neoadjuvant therapy for resectable esophageal cancer: a systematic review and single-arm and network meta-analysis
by: Hesong Wang, et al.
Published: (2023-05-01)

Neoadjuvant concurrent chemoradiotherapy using infusional gemcitabine in locally advanced rectal cancer: A phase II trial
by: Shouki Bazarbashi, et al.
Published: (2022-05-01)

Total neoadjuvant therapy for rectal cancer: evidence and challenge
by: Suk-Hwan Lee
Published: (2023-08-01)

Post-neoadjuvant treatment of breast cancer
by: V. F. Semiglazov, et al.
Published: (2020-07-01)

Survival Outcomes of Patients with Locally Advanced Breast Cancer after Neoadjuvant Systemic Therapy in St. Luke’s Medical Center
by: Cristina G. Domingo, et al.
Published: (2023-05-01)

Overexpression of TaNAC2D displays opposite responses to abiotic stresses between seedling and mature stage of transgenic Arabidopsis
by: Quanjun Huang, et al.
Published: (2016-11-01)

Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go?
by: Chenqi Wang, et al.
Published: (2022-06-01)